Ignite Creation Date:
2025-12-24 @ 2:05 PM
Ignite Modification Date:
2026-01-01 @ 11:50 AM
Study NCT ID:
NCT05076695
Status:
UNKNOWN
Last Update Posted:
2021-10-13
First Post:
2021-09-18
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Neoadjuvant With Trastuzumab, Pyrotinib Plus Palbociclib and Fulvestrant in HER2-positive, ER-positive Breast Cancer
Sponsor:
Fudan University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-10-15
Start Date Type:
ESTIMATED
Primary Completion Date:
2023-10-15
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-10-15
Completion Date Type:
ESTIMATED
First Submit Date:
2021-09-18
First Submit QC Date:
None
Study First Post Date:
2021-10-13
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-09-29
Last Update Post Date:
2021-10-13
Last Update Post Date Type:
ACTUAL